Volume Spike Investor

Dendreon Corp. (NASDAQ: DNDN) is seeing a gap-up this morning after Citigroup started coverage of the prostate cancer PROVENGE owner with a BUY rating and a $35 price target.  Shares closed at $25.61 yesterday, and at 8:17 AM EST we have seen 35,000 shares trade hands.  The last price is $26.45.  As a reminder, the [...]

Dendreon Corporation (NASDAQ: DNDN) is trading up after it was started with a Buy rating and a $36.00 target at Deutsche Bank. Shares are already indicated higher with more than two hours to go before the opening bell.  After a $25.46 close on Thursday, shares are looking up around the $26.75 level.  We have only [...]

Dendreon Corp. (NASDAQ: DNDN) is seeing shares actively traded with a bit more profit taking.  As of 8:27 AM EST we have seen shares down 3% at $21.33 on about 78,000 shares.  The reason for the sell-off is the huge amount of insider share dumping we noticed from Friday after the close.  After a tenfold [...]

So far, we have seen three analyst upgrades over at 24/7 Wall Street that are helping to drive shares higher.  The  last print as of 9:13 AM EST put the stock up at $27.89 on almost 3.6 million shares, above the old $25.00 high of this week. -JON C. OGG

15:05:01 EST NASDAQ has reviewed the transactions under rule 11890 (b) on its own motion filing involving the security Dendreon Corp. (NASDAQ: DNDN) executed between 13:25:00 and 13:27:02 ET today and has determined that all trades will stand. This decision cannot be appealed. JON C. OGG

A call into NASDAQ Marketwatch has confirmed that the NASDAQ is looking into erroneous trading in Dendreon Corporation (NASDAQ: DNDN).  As the NASDAQ has posted: NASDAQ MarketWatch is investigating potentially erroneous transactions involving the security Dendreon Corp. (DNDN) executed between 13:25:00 and 13:27:02 ET today. MarketWatch will advise with details as soon as available. Participants [...]

Cell Genesys, Inc. (NASDAQ: CEGE) has run up 20% on 5-times normal volume today as of 2:12 PM EST.  You can guess why….. This was one of the former Dendreon speculative competitors as far as investors and traders are concerned.  Interestingly enough, we had this one as having canceled its prostate cancer trials before. JON [...]

Dendreon (DNDN) was halted ‘pending news’… unfortunately there was a 45% drop before the halt, but we would caution that this could be bad prints or a bunch of market trades as market makers backed away from the stock.    HALTED 04/28/2009 AT 13:27:02 We will follow up as the news breaks……. JON C. OGG  (1:31 [...]

Dendreon Corporation (NASDAQ: DNDN) is screaming higher this morning.  The company stock is up some 240% at $24.59 after closing at $7.30 before getting halted last night.  Its prior 52-week trading range was $2.55 to $10.00.  At 9:07 AM EST we have already seen 2.6 million shares trade hands and the average volume here is [...]

Dendreon Corp. (NASDAQ: DNDN) is seeing a flurry of stock options activity today yet the stock is not reflecting the volume at all.  We have seen more than 20,000 shares in both PUTS and CALLS in November 2008.  Oddly enough, this is actually before most traders expect big news from PROVENGE. Option/Strike                 Volume    OpInt [...]